Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2007, Vol. 8 Issue (12): 853-859    DOI: 10.1631/jzus.2007.B0853
Quantitative Genetics     
Quantitative analysis of a panel of gene expression in prostate cancer—with emphasis on NPY expression analysis
Liu Ai-jun, Furusato Bungo, Ravindranath Lakshmi, Chen Yong-mei, Srikantan Vasanta, Mcleod David G., Petrovics Gyorgy, Srivastava Shiv
Department of Pathology, Chinese PLA General Hospital, Beijing 100853, China; Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Rockville, MD 20852, USA; Urology Service, Walter Reed Army Medical Center, Washington, DC 20307, USA
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: To investigate molecular alterations associating with prostate carcinoma progression and potentially provide information toward more accurate prognosis/diagnosis. Methods: A set of laser captured microdissected (LCM) specimens from 300 prostate cancer (PCa) patients undergoing radical prostatectomy (RP) were defined. Ten patients representing “aggressive” PCa, and 10 representing “non-aggressive” PCa were selected based on prostate-specific antigen (PSA) recurrence, Gleason score, pathological stage and tumor cell differentiation, with matched patient age and race between the two groups. Normal and neoplastic prostate epithelial cells were collected with LCM from frozen tissue slides obtained from the RP specimens. The expressions of a panel of genes, including NPY, PTEN, AR, AMACR, DD3, and GSTP1, were measured by quantitative real-time RT-PCR (TaqMan), and correlation was analyzed with clinicopathological features. Results: The expressions of AMACR and DD3 were consistently up-regulated in cancer cells compared to benign prostate epithelial cells in all PCa patients, whereas GSTP1 expression was down regulated in each patient. NPY, PTEN and AR exhibited a striking difference in their expression patterns between aggressive and non-aggressive PCas (P=0.0203, 0.0284, and 0.0378, respectively, Wilcoxon rank sum test). The lower expression of NPY showed association with “aggressive” PCas based on a larger PCa patient cohort analysis (P=0.0037, univariate generalized linear model (GLM) analysis). Conclusion: Despite widely noted heterogeneous nature of PCa, gene expression alterations of AMACR, DD3, and GSTP1 in LCM-derived PCa epithelial cells suggest for common underlying mechanisms in the initiation of PCa. Lower NPY expression level is significantly associated with more aggressive clinical behavior of PCa; PTEN and AR may have potential in defining PCa with aggressive clinical behavior. Studies along these lines have potential to define PCa-associated gene expression alterations and likely co-regulation of genes/pathways critical in the biology of PCa onset/progression.

Key wordsProstate cancer      NPY expression      Quantitative real-time reverse-transcript polymerase chain reaction (RT-PCR)     
Received: 15 October 2007     
CLC:  R737  
Cite this article:

Liu Ai-jun, Furusato Bungo, Ravindranath Lakshmi, Chen Yong-mei, Srikantan Vasanta, Mcleod David G., Petrovics Gyorgy, Srivastava Shiv. Quantitative analysis of a panel of gene expression in prostate cancer—with emphasis on NPY expression analysis. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(12): 853-859.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.2007.B0853     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2007/V8/I12/853

[1] You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 756-760.
[2] Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha. Prostate cancer: the need for biomarkers and new therapeutic targets[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 16-42.
[3] BALACHANDAR V., LAKSHMAN KUMAR B., SASIKALA K., MANIKANTAN P., SANGEETHA R., MOHANA DEVI S.. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(9): 638-646.